Talk Bio

No recent news about former employee suing BioNTech for cutting corners in pancreatic cancer trials found in current search results. The available information does not mention any such lawsuit or allegations related to BioNTech or pancreatic cancer trials involving a former employee. Thus, there is no recent news on this specific claim at this time.

Moderna Eyes German Vaccine Facilities as Senate Democrats Push Broad Drug Pricing Reforms

Gilead Cuts Over 300 Jobs at Arcellx Post-$7.8B Acquisition as BioNTech Plans 1,860 Layoffs

BioNTech Shuts Down COVID Vaccine Production, Closing Sites and Cutting 1,860 Jobs

BioNTech Founders Ugur Sahin and Özlem Türeci to Depart and Launch New mRNA Venture

Aardvark Therapeutics Stock Plunges 54% Following Phase 3 Trial Pause

BioNTech and UPenn Launch $50M Seed Fund for Early-Stage Biotechs

BioNTech and UPenn Launch $50M Seed Fund for Early-Stage Biotechs

BioNTech and UPenn Launch $50M Seed Fund for Early-Stage Biotechs

Genmab Discontinues Phase III Development of Acasunlimab Lung Cancer Asset Previously Ditched by BioNTech

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig in Advanced Triple-Negative Breast Cancer

Pfizer Reduces Stake in BioNTech; Candel Pauses Pancreatic Cancer Program

BioNTech and BMS Announce First Global Data for PD-L1xVEGF Bispecific in Small Cell Lung Cancer, Set Phase 3 Dose

BioNTech and DualityBio Achieve Phase 3 Success with ADC Therapy for HER2-Positive Breast Cancer, Advancing Oncology Pipeline

GSK set to receive over $500M from mRNA patent settlement tied to BioNTech–CureVac–Pfizer deal

BioNTech to Cut 90 More US Jobs Amid Strategic Realignment

Moderna Wins UK Appeals Court in Covid-19 Patent Case Against Pfizer/BioNTech

BioNTech Chief Strategy Officer Departs Amid Oncology Pivot and Major Deals

BioNTech Halts Cell Therapy Manufacturing at Maryland Site, Lays Off Dozens

BioNTech Acquires CureVac to Advance mRNA Cancer Therapies and End Patent Disputes